Key result
Myocardial fibrosis, estimated by integrated backscatter, was an independent determinant of diastolic dysfunction in patients on chronic haemodialysis.
Why the study?
Is myocardial fibrosis associated with left ventricular diastolic dysfunction in patients with ESRD on chronic haemodialysis?
Observational (n=25)
Is myocardial fibrosis associated with left ventricular diastolic dysfunction in patients with ESRD on chronic haemodialysis?
In patients with ESRD on hemodialysis, myocardial fibrosis estimated by ultrasound integrated backscatter is independently associated with left ventricular diastolic dysfunction.
Answers are grounded in this paper and cite their sources.
May aid risk stratification in hemodialysis diastolic dysfunction; leaves open causal role and need for prospective trials.
BACKGROUND: Left ventricular (LV) diastolic dysfunction is linked to myocardial collagen content in many cardiac diseases. There are no data regarding such relationship in patients with end-stage renal disease (ESRD) undergoing haemodialysis. METHODS: Twenty-five patients with ESRD undergoing haemodialysis were studied by echocardiography. LV diastolic function was investigated by Doppler echocardiography, by analysing LV filling velocities at rest and during loading manoeuvres, which represent an estimate of LV filling pressure. According to the Doppler pattern, LV filling pressure in a given patient was judged to be normal or slightly increased or to be moderately or severely increased. The presence of myocardial fibrosis was estimated by ultrasound tissue characterization with integrated backscatter, which in diastole correlates with the collagen content of the myocardium. RESULTS: Integrated backscatter was higher in patients with moderate or severely increased than in patients with normal or slightly increased LV filling pressure (integrated backscatter: 51.0 +/- 9.8 vs 41.6 +/- 5.6%; P = 0.008). Integrated backscatter was a strong and independent determinant of diastolic dysfunction (odds ratio = 1.212; P = 0.040). CONCLUSION: Our data support the hypothesis that, in a selected population of patients with ESRD undergoing haemodialysis, myocardial fibrosis is associated with LV diastolic myocardial properties.
No takes yet. Share an insight, caveat, or question.
Losi et al. (2010) conducted an observational in End-stage renal disease undergoing haemodialysis (n=25). Myocardial fibrosis (integrated backscatter) vs. Lower integrated backscatter was evaluated on Diastolic dysfunction (OR 1.212, p=0.040). Myocardial fibrosis, estimated by integrated backscatter, was an independent determinant of diastolic dysfunction in patients on chronic haemodialysis.
Synapse has enriched 10 related papers. Consider them for comparative context: